Astrana Health, Inc. (NASDAQ:ASTH) is one of the best small cap stocks to buy for 10x potential. On May 8, Baird lifted the ...

Earlier in May 2026, Astrana Health reported first-quarter revenue of US$965.1 million and net income of US$14.44 million, reaffirmed its 2026 revenue outlook, announced Chief Medical Officer Dinesh ...

As of May 22, 2024, the average one-year price target for Astrana Health is 50.76. The forecasts range from a low of 33.71 to a high of $73.50. The average price target represents an increase of 28.39 ...

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...

The average one-year price target for Astrana Health (NasdaqCM:ASTH) has been revised to $44.43 / share. This is an increase ...

Healthcare services company Astrana Health reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up ...

Diamond Hill Capital, an investment management company, released its “Small Cap Fund” second-quarter 2024 investor letter. A copy of the same can be downloaded here. Equity markets reported mixed ...

Astrana Health, Inc. offers a mispriced growth opportunity, combining 20–30% top and bottom line growth with strong free cash flow and operational leverage. ASTH's risk-bearing, tech-enabled model ...

Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Astrana Health, Inc. (ASTH) and U.S. Physical Therapy (USPH). But which of these ...